title: Epidermal growth factor (EGF) sustains in vitro primordial follicle viability by enhancing stromal cell proliferation via MAPK and PI3K pathways in the prepubertal, but not adult, cat ovary.
abstract: This study examined the influences of epidermal growth factor (EGF) and growth differentiation factor 9 (GDF9) on in vitro viability and activation of primordial follicles in the ovarian tissue of prepubertal (age, <6 mo) versus adult (age, >8 mo) cats. Ovarian cortical slices were cultured in medium containing EGF and/or GDF9 for 14 days. EGF, but not GDF9, improved (P < 0.05) follicle viability in prepubertal donors in a dose-dependent fashion. Neither EGF nor GDF9 enhanced follicle viability in ovarian tissue from adults, and neither factor activated primordial follicles regardless of age group. We then explored how EGF influenced primordial follicles in the prepubertal donors by coincubation with an inhibitor of EGF receptor (AG1478), mitogen-activated protein kinase (MAPK; U0126), or phosphoinositide 3-kinase (PI3K; LY294002). EGF enhanced (P < 0.05) MAPK and AKT phosphorylation, follicle viability, and stromal cell proliferation. These effects were suppressed (P < 0.05) when the tissue was cultured with this growth factor combined with each inhibitor. To identify the underlying influence of age in response to EGF, we assessed cell proliferation and discovered a greater thriving stromal cell population in prepubertal compared to adult tissue. We conclude that EGF plays a significant role in maintaining intraovarian primordial follicle viability (but without promoting activation) in the prepubertal cat. The mechanism of action is via stimulation of MAPK and PI3K signaling pathways that, in turn, promote ovarian cell proliferation. Particularly intriguing is that the ability of cat ovarian cells to multiply in reaction to EGF is age-dependent and highly responsive in prepubertal females.
authors.affiliation: Center for Species Survival, Smithsonian Conservation Biology Institute, National Zoological Park, Front Royal, Virginia.
authors.forename: Mayako
authors.initials: M
authors.lastname: Fujihara
authors.forename: Pierre
authors.initials: P
authors.lastname: Comizzoli
authors.forename: Carol L
authors.initials: CL
authors.lastname: Keefer
authors.forename: David E
authors.initials: DE
authors.lastname: Wildt
authors.forename: Nucharin
authors.initials: N
authors.lastname: Songsasen
mesh_terms: D000367:Age Factors; D000818:Animals; D002415:Cats; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D004815:Epidermal Growth Factor / Q000494:pharmacology / Q000502:physiology*; D005260:Female; D055429:Growth Differentiation Factor 9 / Q000494:pharmacology / Q000502:physiology; D020935:MAP Kinase Signaling System / Q000187:drug effects / Q000502:physiology*; D006080:Ovarian Follicle / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D012741:Sexual Maturation / Q000502:physiology; D017154:Stromal Cells / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism
chemical_list: D055429:Growth Differentiation Factor 9; D004815:Epidermal Growth Factor; D019869:Phosphatidylinositol 3-Kinases
keywords: cat; folliculogenesis; in vitro culture; ovary; primordial follicle